Product Information

AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2626 per EA under NDC 62332021430. Its NADAC has been published 450 times since Nov 15, 2017.

AMLODIPINE-OLMESARTAN 10-20 MG

Amlodipine besylate and Olmesartran medoxomil
$0.2626per EA

Strength

10; 20 mg/1; mg/1

NDC

62332021430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207073

On Market Since

7/18/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 450 times since Nov 15, 2017, and over the history we have for it it has declined 72.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2626 per EA
All-time high$0.9674 (Aug 14, 2019)
All-time low$0.2626 (Jun 17, 2026)
52-week high$0.3713
52-week low$0.2626
Median price$0.4368
Average price$0.5091
Largest weekly change+68.6% (Nov 22, 2023)
Weeks tracked450
Tracking sinceNov 15, 2017

Price History

1W

0.0%

1M

-11.1%

3M

-13.7%

6M

-18.2%

1Y

-27.7%

3Y

-22.0%

5Y

-42.3%

All

-72.7%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Alembic Pharmaceuticals Inc., is $0.2626 per EA (NDC 62332021430), effective Jun 24, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 72.7%. It has been tracked across 450 weekly CMS publications since Nov 15, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?

Since Nov 15, 2017, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2626 (Jun 17, 2026) to a high of $0.9674 (Aug 14, 2019), with a median of $0.4368 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 10-20 MG, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?

AMLODIPINE-OLMESARTAN 10-20 MG (NDC 62332021430) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.